mRNA vaccines lead next-generation efforts to combat H5N1 amid global outbreaks: GlobalData
mRNA technology could transform H5N1 vaccine landscape, enhancing future pandemic preparedness says GlobalData
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Ind-Ra forecasts weak API prices and volume growth for India in FY25
Decline in raw material costs and forward integration into formulations business help mitigate impact on margins
Dr R N Gupta elected National President of Indian Pharmaceutical Association for 2024-2026 term
Senior pharmaceutical professional to lead association as other office bearers are announced for new term
GS1 India hosts healthcare conference on ‘Navigating the Future of Healthcare’
The conference aimed to serve as a platform for the stakeholders to discuss strategies for enhancing healthcare delivery through…
USFDA concludes GMP inspection at Dr Reddy’s R&D centre
The inspection was conducted from September 16 to September 20, 2024. The inspection closed with zero observations
Pharma sector set for 8-10 per cent revenue growth this fiscal
The resultant improvement in operating leverage along with easing pricing pressure in the US generics market will improve…
AstraZeneca to launch Palivizumab (Synagis) in India
AstraZeneca will launch Palivizumab (Synagis) in October 2024 in India
Fermenta Biotech’s Dahej facility gains EU GMP certification
The API manufacturing facility received the GMP certification from the Competent Authority of Germany
Atopic Dermatitis: A hotspot for innovation and investment opportunities, says GlobalData
With the growth in AD, investment opportunities seem to be exciting, and pharmaceutical companies could invest in the R&D of…
Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
The total investment incurred for setting up the new R&D is Rs 250 crore
Cabinet approves ‘Bio-RIDE’ scheme to support R&D in Biotechnology
The scheme is part of the Government of India’s mission to harness the potential of bio-innovation to tackle national and global…
Eppendorf India and Rajalakshmi Engineering College sign MoU for training students
A team of Eppendorf experts would conduct the training on various modules such as liquid handling, centrifugation, extraction and…
Piramal Pharma’s GHG commitment validated and approved by SBTi
Piramal has committed to reducing absolute scope 1 and 2 GHG emissions by 42 per cent by FY2030 from an FY2022 base year. It has…
Industry hails Bio E3 policy as transformative for India’s biotech sector
Aim to spur India's bio economy to an aspirational $300 billion by 2030
Pfizer sets up Analytics Gateway capability centre in India
The capability centre aims to accelerate Pfizer’s growth across the 140 countries (ex-US) where it is present, powered by data,…
Lupin gets US FDA nod for Bumetanide Injection, USP
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of $ 20 million in the US (IQVIA MAT July 2024)
DBT-BIRAC partners with Blockchain For Impact to accelerate bio-medical innovation in India
Aligned to the recently approved BioE3 policy, the partnership will fast-track innovation and tech-driven support in the…
Lupin partners with Takeda to commercialise Vonoprazan
The drug will be marketed under the brand name Lupin’s Lupivon and will be available in two strengths - 10 mg and 20 mg
Eugia Steriles receives EIR from US FDA
The inspection was conducted between March 28, 2024 to April 05, 2024
Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030
GlobalData analyst consensus forecast predicts the global revenue of Pluvicto to rise from $980 million in 2023 to $4.3 billion by…